ENZ
Income statement / Annual
Last year (2024), Enzo Biochem, Inc.'s total revenue was $31.91 M,
an increase of 2.72% from the previous year.
In 2024, Enzo Biochem, Inc.'s net income was -$26.08 M.
See Enzo Biochem, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
07/31/2024 |
07/31/2023 |
07/31/2022 |
07/31/2021 |
07/31/2020 |
07/31/2019 |
07/31/2018 |
07/31/2017 |
07/31/2016 |
07/31/2015 |
| Operating Revenue |
$31.91 M
|
$31.06 M
|
$107.07 M
|
$117.73 M
|
$76.02 M
|
$81.17 M
|
$104.71 M
|
$107.80 M
|
$102.77 M
|
$97.60 M
|
| Cost of Revenue |
$17.28 M |
$19.50 M |
$65.10 M |
$64.15 M |
$52.25 M |
$57.92 M |
$60.39 M |
$59.48 M |
$57.19 M |
$54.77 M |
| Gross Profit |
$14.63 M |
$11.57 M |
$41.97 M |
$53.58 M |
$23.77 M |
$23.25 M |
$44.33 M |
$48.33 M |
$45.58 M |
$42.83 M |
| Gross Profit Ratio |
0.46 |
0.37 |
0.39 |
0.46 |
0.31 |
0.29 |
0.42 |
0.45 |
0.44 |
0.44 |
| Research and Development
Expenses |
$2.64 M
|
$3.90 M
|
$3.77 M
|
$3.25 M
|
$4.45 M
|
$3.18 M
|
$3.21 M
|
$2.93 M
|
$3.52 M
|
$3.35 M
|
| General & Administrative
Expenses |
$24.36 M
|
$27.20 M
|
$53.71 M
|
$44.91 M
|
$49.69 M
|
$44.27 M
|
$44.47 M
|
$44.01 M
|
$43.59 M
|
$41.07 M
|
| Selling & Marketing
Expenses |
$0.00
|
$345,000.00
|
$577,000.00
|
$400,000.00
|
$437,000.00
|
$374,000.00
|
$580,000.00
|
$649,000.00
|
$601,000.00
|
$556,000.00
|
| Selling, General &
Administrative Expenses |
$24.36 M
|
$27.20 M
|
$53.71 M
|
$44.91 M
|
$42.96 M
|
$44.27 M
|
$44.47 M
|
$44.01 M
|
$43.59 M
|
$41.07 M
|
| Other Expenses |
$2.63 M |
$380,000.00 |
-$1.19 M |
$6.91 M |
$488,000.00 |
$382,000.00 |
$168,000.00 |
$125,000.00 |
$122,000.00 |
$95,000.00 |
| Operating Expenses |
$27.00 M |
$31.11 M |
$57.47 M |
$48.16 M |
$47.41 M |
$47.44 M |
$51.37 M |
$49.71 M |
$49.45 M |
$46.70 M |
| Cost And Expenses |
$44.27 M |
$50.60 M |
$122.58 M |
$112.31 M |
$99.66 M |
$105.36 M |
$111.75 M |
$109.19 M |
$106.64 M |
$101.48 M |
| Interest Income |
$3.54 M |
$0.00 |
$178,000.00 |
$8,000.00 |
$454,000.00 |
$1.06 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$197,000.00 |
$0.00 |
$159,000.00 |
$0.00 |
$0.00 |
$0.00 |
$9.78 M |
$2.58 M |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.27 M
|
$2.68 M
|
$2.83 M
|
$2.65 M
|
$2.78 M
|
$3.04 M
|
$3.13 M
|
$3.60 M
|
$3.84 M
|
$3.79 M
|
| EBITDA |
-$8.35 M
|
-$22.34 M
|
-$15.01 M
|
$3.35 M
|
-$27.59 M
|
-$24.16 M
|
-$3.91 M
|
$1.09 M
|
-$6.56 M
|
-$1.21 M
|
| EBITDA Ratio |
-0.26 |
-0.39 |
-0.1 |
0.11 |
-0.2 |
1 |
1 |
1 |
1 |
-0.02 |
| Operating Income Ratio
|
-0.39
|
-0.8
|
-0.14
|
0.08
|
-0.31
|
0.96
|
-0.12
|
-0.03
|
0.46
|
-0.01
|
| Total Other
Income/Expenses Net |
$0.00
|
-$286,000.00
|
-$3.31 M
|
$7.18 M
|
$1.85 M
|
$756,000.00
|
$746,000.00
|
$644,000.00
|
-$488,000.00
|
-$1.09 M
|
| Income Before Tax |
-$9.82 M |
-$25.02 M |
-$18.26 M |
$7.88 M |
-$28.52 M |
$2.49 M |
-$11.42 M |
-$2.42 M |
$46.52 M |
-$2.29 M |
| Income Before Tax Ratio
|
-0.31
|
-0.81
|
-0.17
|
0.07
|
-0.38
|
0.03
|
-0.11
|
-0.02
|
0.45
|
-0.02
|
| Income Tax Expense |
$16.26 M |
$12.30 M |
$4.32 M |
$4.45 M |
$5.37 M |
$101.27 M |
-$1.10 M |
$82,000.00 |
$1.23 M |
-$7,000.00 |
| Net Income |
-$26.08 M |
$20.29 M |
-$22.58 M |
$3.43 M |
-$33.89 M |
-$98.78 M |
-$10.32 M |
-$2.50 M |
$45.29 M |
-$2.29 M |
| Net Income Ratio |
-0.82 |
0.65 |
-0.21 |
0.03 |
-0.45 |
-1.22 |
-0.1 |
-0.02 |
0.44 |
-0.02 |
| EPS |
-0.51 |
-1.27 |
-0.46 |
0.0711 |
-0.71 |
-2.09 |
-0.22 |
-0.054 |
0.98 |
-0.0504 |
| EPS Diluted |
-0.51 |
-1.27 |
-0.46 |
0.0709 |
-0.71 |
-2.08 |
-0.22 |
-0.054 |
0.97 |
-0.0504 |
| Weighted Average Shares
Out |
$50.90 M
|
$49.16 M
|
$48.59 M
|
$48.19 M
|
$47.70 M
|
$47.35 M
|
$46.91 M
|
$46.35 M
|
$46.15 M
|
$45.36 M
|
| Weighted Average Shares
Out Diluted |
$50.90 M
|
$49.16 M
|
$48.59 M
|
$48.33 M
|
$47.70 M
|
$47.48 M
|
$46.97 M
|
$46.35 M
|
$46.60 M
|
$45.36 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
